Depression Drugs Market: By Medication Class, Serotonin-Norepinephrine Reuptake Inhibitors, Anticonvulsants, Beta-Blockers, Benzodiazepines, Others; By Brand - Forecast 2016-2021 - Product Thumbnail Image

Depression Drugs Market: By Medication Class, Serotonin-Norepinephrine Reuptake Inhibitors, Anticonvulsants, Beta-Blockers, Benzodiazepines, Others; By Brand - Forecast 2016-2021

  • Report
  • 141 Pages
From
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential - Product Thumbnail Image

Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential

  • Report
  • 199 Pages
From
Depression and Anxiety Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Depression and Anxiety Disorders Drug Development Pipeline Review, 2018

  • Report
  • 175 Pages
From
Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD): Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 191 Pages
From
Abilify/Abilify Maintena - Product Thumbnail Image

Abilify/Abilify Maintena

  • Report
  • 61 Pages
From
Drug Overview: Saphris - Product Thumbnail Image

Drug Overview: Saphris

  • Report
  • 34 Pages
From
Drug Overview: Rexulti - Product Thumbnail Image

Drug Overview: Rexulti

  • Report
  • 28 Pages
From
Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2016 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2016

  • Drug Pipelines
  • 73 Pages
From
Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2018 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Abilify Maintena 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Abilify Maintena 2017 U.S. Promotional Audit Report

  • Report
  • 21 Pages
From
Rexulti 2017 U.S. Promotional Audit Report - Product Thumbnail Image

Rexulti 2017 U.S. Promotional Audit Report

  • Report
  • 21 Pages
From
Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments - Product Thumbnail Image

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

  • Report
  • 133 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
Alzheimer s: Epidemiology Overview and Insights - Product Thumbnail Image

Alzheimer s: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Alzheimer's: Disease Inights and Market Forecasts to 2024 - Product Thumbnail Image

Alzheimer's: Disease Inights and Market Forecasts to 2024

  • Report
  • 120 Pages
From
Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2016 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2016

  • Drug Pipelines
  • 77 Pages
From
Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2015 - Product Thumbnail Image

Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2015

  • Drug Pipelines
  • 59 Pages
From
Alzheimer'S Disease: Pharmacuetical Drugs Vs. Medicinal Plants - Markets, Competitors and Opportunities: 2015-2020 Analysis and Forecasts - Product Thumbnail Image

Alzheimer'S Disease: Pharmacuetical Drugs Vs. Medicinal Plants - Markets, Competitors and Opportunities: 2015-2020 Analysis and Forecasts

  • Report
  • 77 Pages
From
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets - Product Thumbnail Image

Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

  • Report
  • 144 Pages
From
Loading Indicator
adroll